Trials / Completed
CompletedNCT00742729
Increasing Colorectal Cancer Screening Among Filipino Americans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 906 (actual)
- Sponsor
- Jonsson Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Develop and evaluate in a randomized trial an educational small group intervention to increase colorectal cancer screening among Filipino Americans.
Detailed description
The purpose of this research study is to increase colorectal cancer (CRC) screening among older Filipino Americans, specifically the use of fecal occult blood tests (FOBTs). We will design a culturally specific intervention, an educational small group discussion with a Filipino health professional. The effect of the intervention will be tested with 620 Filipino Americans. Subjects will be recruited at community-based organizations and churches and invited to join a 1 1/2 hour discussion of health issues with their partner and some of their friends. A third of the subjects will discuss exercise (control group), another third will discuss CRC and receive an FOBT kit, and the remaining third will discuss CRC and will not receive an FOBT kit. Three months after the group session, subjects in the CRC (intervention) groups will receive a letter reminding them to get screened. All subjects will be interviewed before and 6 months after the group sessions to assess CRC screening levels in the three groups. Self-reported CRC screening will be verified by a review of their medical records.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Arm 1 | Educational small group session with free FOBT kit |
| BEHAVIORAL | Arm 2 | Educational small group session with no FOBT kit |
| BEHAVIORAL | Arm 3 | Educational small group session, exercise |
Timeline
- Start date
- 2004-09-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2008-08-28
- Last updated
- 2016-08-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00742729. Inclusion in this directory is not an endorsement.